These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 20209869)

  • 1. [Efficacy of combined treatment of large prostatic adenoma with doxasozine and finasteride].
    Tarasov NI; Izmaĭlov RI
    Urologiia; 2009; (5):40-5. PubMed ID: 20209869
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Efficacy and safety of doxazosine in combination with finasteride in the treatment of prostatic adenoma].
    Bogdanov AB; Luk'ianov IV; Veliev EI
    Urologiia; 2008; (6):44-9. PubMed ID: 19248599
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two-drug therapy is best for symptomatic prostate enlargement: could a combination of doxazosin and finasteride change clinical practice?
    Fitzpatrick JM; Kirby RS
    BJU Int; 2004 May; 93(7):914-5. PubMed ID: 15142134
    [No Abstract]   [Full Text] [Related]  

  • 4. [Therapy of benign prostatic hyperplasia with finasteride and doxazosin -- long-term studies support the combination].
    Hausmann R; Thalmann G; Reich O; Steif CG
    Aktuelle Urol; 2004 Sep; 35(5):339-42. PubMed ID: 15383991
    [No Abstract]   [Full Text] [Related]  

  • 5. [Finasteride preoperative preparation of patients with prostatic adenoma to transurethral prostatic resection].
    Tkachuk VN; Al'-Shukri SKh; Tkachuk IN
    Urologiia; 2008; (1):27, 29, 31. PubMed ID: 18652018
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Using doxasosine and finasteride combination in the treatment of prostate adenoma].
    Bogdanov AB; Luk'ianov IV; Veliev EI
    Urologiia; 2006; (5):59-63. PubMed ID: 17444154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [5-alpha reductase inhibitors or alpha blockers? The combination brakes best prostatic hyperplasia].
    MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494605
    [No Abstract]   [Full Text] [Related]  

  • 8. The impact of 5-alpha-reductase inhibitors on the number of prostatectomies for benign prostatic hyperplasia.
    Agha AH; Roy JB; Culkin DJ; Lyon K
    Adv Ther; 1995; 12(6):361-6. PubMed ID: 10163332
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Second opinion. I have benign prostatic hyperplasia. The drug my doctor prescribed has helped somewhat, but I'm still making a lot of trips to the bathroom at night. Short of surgery, are there any new approaches to managing this condition that might be more helpful?
    Mayo Clin Health Lett; 2002 Dec; 20(12):8. PubMed ID: 12526112
    [No Abstract]   [Full Text] [Related]  

  • 10. An economic evaluation of doxazosin, finasteride and combination therapy in the treatment of benign prostatic hyperplasia.
    McDonald H; Hux M; Brisson M; Bernard L; Nickel JC
    Can J Urol; 2004 Aug; 11(4):2327-40. PubMed ID: 15380054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Two drugs have a better outcome. Finasteride plus alpha blocker improves urine flow].
    MMW Fortschr Med; 2003 Nov; 145(47):62. PubMed ID: 14725041
    [No Abstract]   [Full Text] [Related]  

  • 12. [Benign prostatic hyperplasia: medical therapy].
    Schlenker B; Gratzke C; Weidlich P; Seitz M; Reich O; Stief CG
    MMW Fortschr Med; 2007 Aug; 149(33-34):29-31; quiz 32. PubMed ID: 17912863
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Changes in microcirculation of the urinary bladder in patients with stage II prostatic adenoma depending on the treatment method].
    Pavlov VN; Kazikhinurov AA; Ishemgulov RR; Mustafin AT
    Urologiia; 2008; (1):31-2, 34-5. PubMed ID: 18649676
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Combined use of 5 alpha-reductase inhibitors and alpha-l adrenergic receptor blockers in patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Luk'ianov AE; Kornienko VI; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (3):5-8. PubMed ID: 9644979
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Finasteride and doxazosin alone or in combination for the treatment of benign prostatic hyperplasia.
    Bhardwa J; Goldstraw M; Tzortzis S; Kirby R
    Expert Opin Pharmacother; 2007 Jun; 8(9):1337-44. PubMed ID: 17563267
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Long-term results of proscar (finasteride, MSD) treatment of patients with benign prostatic hyperplasia].
    Tkachuk VN; Al'-Shukri SKh; Kornienko VI; Kuz'min IV
    Urol Nefrol (Mosk); 1998; (4):37-9. PubMed ID: 9727320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The experience in dutasteride use before transurethral prostatic resection for large adenoma].
    Martov AG; Ergakov DV
    Urologiia; 2008; (4):46, 48-50, 52. PubMed ID: 19054996
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Therapy of benign prostatic hyperplasia: terazosin or finasteride?].
    Trinkler FB
    Praxis (Bern 1994); 1997 Aug; 86(34):1305-6. PubMed ID: 9381019
    [No Abstract]   [Full Text] [Related]  

  • 19. Combination therapy with doxazosin and finasteride for benign prostatic hyperplasia in patients with lower urinary tract symptoms and a baseline total prostate volume of 25 ml or greater.
    Kaplan SA; McConnell JD; Roehrborn CG; Meehan AG; Lee MW; Noble WR; Kusek JW; Nyberg LM;
    J Urol; 2006 Jan; 175(1):217-20; discussion 220-1. PubMed ID: 16406915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [5-alpha reductase inhibitors plus alpha blockers. A combination therapy keeps a common disease checked].
    MMW Fortschr Med; 2003 Jul; 145(27-28):58-9. PubMed ID: 14587193
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.